Citigroup
MIRA icon

Citigroup’s MIRA Pharmaceuticals MIRA Stock Holding History

Citigroup’s Portfolio MIRA Stock Details MIRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.52K Buy
+4,226
New +$5.3K ﹤0.01% 5286
2025
Q4 		– Sell
-3,820
Closed -$5.2K – 6302
2025
Q3 		$5.2K Buy
+3,820
New +$5.54K ﹤0.01% 5219

Other funds holding MIRA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CSI
Cross Staff Investments Pittsford, New York $178M AUM 21.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SEM
Suncoast Equity Management Tampa, Florida $833M AUM 11.9% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
FAB
First American Bank Dundee, Illinois $1.79B AUM 30.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Citigroup's MIRA Position: Q1 2026 in Review

Citigroup opened a new position in MIRA Pharmaceuticals (MIRA) in Q1 2026: 4,226 shares worth $4.52K. The stake represents ﹤0.01% of the portfolio and ranks #5286 among its holdings. This is a return to the name: Citigroup previously reported a position in MIRA as recently as Q3 2025.

Citigroup first reported a position in MIRA in Q3 2025 and has held it in 2 quarters since. The position peaked at $5.2K in Q3 2025. 26 funds tracked by Wall St. Rank hold MIRA as of Q1 2026.

  • Citigroup held 4,226 shares of MIRA Pharmaceuticals worth $4.52K as of Q1 2026.
  • MIRA Pharmaceuticals was a new Citigroup position in Q1 2026.
  • MIRA Pharmaceuticals made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5286 holding.
  • Citigroup first reported a position in MIRA Pharmaceuticals in Q3 2025 and has held it in 2 quarters since.
  • Citigroup's MIRA Pharmaceuticals position peaked at $5.2K in Q3 2025.
  • 26 funds tracked by Wall St. Rank held MIRA Pharmaceuticals as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.